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Staphylococcus simulans is a coagulase-negative organism, mainly an animal pathogen. Reports of human infection have been
infrequent, mainly in patients with repeated animal contact. We report the ﬁrst case of pleural empyema in an elderly woman. S.
simulans tends to cause more severe infection because of a bioﬁlm layer which helps in adherence and colonization of smooth
surfaces, especially prosthetic devices, shunts, and catheters.(e challenging problem even after CoNS isolation and identiﬁcation
is the assessment of their clinical relevance. Major factors that inhibit the penetration of antibiotics is the large-sized
eﬀusions/empyema, thickness of pleura, and the nature of antibiotic itself. Source control for septic patients remains the
cornerstone of treatment along with optimal antimicrobial coverage. Staphylococcus simulans, a coagulase-negative staphylo-
coccus, is emerging as an important cause of virulent infections with highmortality in humans. Given its propensity for multidrug
resistance, including vancomycin, there is an imperative for early and accurate identiﬁcation of the isolate. Despite aggressive
treatment, the patient succumbed to her illness.
1. Introduction
Staphylococcus simulans is a coagulase-negative staphylo-
coccus. It is mainly an animal pathogen and has been found
to cause bovine mastitis. It can occasionally colonize the
human skin. Human infections with Staphylococcus simu-
lans have rarely been reported, mainly in patients who have
repeated contact with animals. We report the ﬁrst case of
pleural empyema caused by S. simulans.
1.1.CaseReport. An 80-year-old woman was admitted to the
hospital after a fall. Her prior history was notable for cor-
onary artery disease status post percutaneous intervention,
poorly controlled type 2 diabetes mellitus, congestive heart
failure, hypothyroidism, and atrial ﬁbrillation. She had had
multiple mechanical falls in the past with cervical spine and
right-sided rib fractures. She had no recent hospitalization in
the last 90 days and has been living at home prior to pre-
sentation. (ere was no history of exposure to the farm
animals. During this hospitalization, she developed pro-
gressive dyspnea and hypoxia. Computed tomography (CT)
revealed a bilateral pleural eﬀusion, right more than left, with
diﬀuse interlobular septal thickening. Note was also made of
a diﬀuse, mosaic-like attenuation of the lung parenchyma,
likely related to air trapping or obstructive small airway
disease. (ere was no pleural enhancement, septations, or air
noted within the pleural space (Figure 1(a)). She was noted to
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have new fracture of right posterior seventh, eighth, and ninth
ribs. Laboratory data at admission revealed a white blood cell
(WBC) count of 9.7 × 1000/µL (with 83% neutrophils and 1%
eosinophils). Her hemoglobin was 11.09 g/dL, hematocrit
40.6%, platelets 143 × 1000/µL, total protein 5.1 g/dL, blood
urea nitrogen (BUN) 31mg/dL, serum creatinine 1.51mg/dL,
serum sodium (Na) 145mEq/L, chloride (Cl) 102mEq/L,
potassium (K) 3.6mEq/L, aspartate aminotransferase (AST)
24 IU/L, and lactate dehydrogenase (LDH) 472 IU/L. Serum
procalcitonin levels were elevated to 0.59 ng/mL (normal 0.00
– 0.08 ng/mL) and hemoglobin A1C (HbA1C) to 8.9%.
Blood cultures prior to initiation of antimicrobial
therapy returned negative. Sputum culture was negative for
bacteria, including acid-fast bacilli. Transthoracic echocar-
diography was unremarkable.
(e patient was treated initially with levoﬂoxacin and
ampicillin/sulbactam for a pneumonia and parapneumonic
pleural eﬀusion. Despite antimicrobial therapy, her re-
spiratory status continued to deteriorate and within 48 hours
of hospitalization required endotracheal intubation and
ventilatory support. A thoracentesis yielded 250ml of pus
(WBCs more than 50,000 with 95% neutrophils, elevated
protein 3.6 g/dL (normal 0.0–2.4 g/dL), LDH 13461 IU/L,
glucose 6mg/dL, and pH 6.94). A right-sided thoracostomy
was performed to facilitate evacuation of the empyema using
a 32 French (F) thoracostomy tube. Postprocedure chest
X-ray conﬁrmed the optimal placement of the tube (Figure 2).
Gram stains obtained from the pleural ﬂuid collected under
sterile conditions revealed gram-positive cocci, and her an-
tibiotics were changed to vancomycin. (e ﬁnal isolate on
culture and sensitivity was identiﬁed as S. simulanswith heavy
growth, susceptible to vancomycin and clindamycin only. A
repeat CT scan of the chest revealed a persistent collection of
right-sided empyema (Figure 1(b)). Ultrasound imaging of
the pleural collections did not demonstrate any septations or
loculated pockets on either side. Second attempt was made to
evacuate the pleural collection with the use of intrapleural
ﬁbrinolytic tissue plasminogen activator (t-PA) with little
success. (e patient was considered a high-risk candidate for
surgical intervention considering her frailty and othermedical
comorbidities. Her course was further complicated by cir-
culatory shock requiring vasopressor supports and atrial ﬁ-
brillation with rapid ventricular response requiring multiple
rate-controlling drugs. After about 3 weeks of a tenuous
course, her family elected to withdraw care and she passed
away very shortly thereafter.
2. Discussion
Coagulase-negative staphylococcus (CoNS) has become an
important cause of nosocomial infections. Common human
isolates are Staphylococcus epidermidis, Staphylococcus
capitis, Staphylococcus hominis, Staphylococcus haemolyti-
cus, Staphylococcus warneri, Staphylococcus caprae, Staph-
ylococcus saccharolyticus, Staphylococcus pasteuri,
Staphylococcus saprophyticus, and Staphylococcus lugdu-
nensis [1].
S. simulans commonly aﬀects cows, sheep, goats, and
horses. Human infections are rare, and the literature has
commonly reported soft tissue infection, osteomyelitis,
bacteremia, urinary tract infection, prosthetic joint in-
fection, and native valve endocarditis [1–8] (Table 1). A case
of pneumonia was reported by de Jesus et al. which revealed
S. simulans in blood culture and CoNS in sputum culture [2].
(a) (b)
Figure 1: (a) CTchest showing bilateral empyema (right more than left). (b) CTchest showing persistent bilateral empyema after attempted
drainage through chest drains.
Figure 2: Chest X-ray showing the right-sided chest tube (green
arrows), positioned in the most dependent area.
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de Jesus et al. also reported a case of acute respiratory failure,
ARDS with blood culture growing S. simulans [2]. To the
best of our knowledge, this is the ﬁrst case of pleural em-
pyema caused by S. simulans. In our patient, there was no
history of contact with animals. Mode of acquisition of
infection in our patient remained unclear.
S. simulans tends to cause more severe infection because
of a bioﬁlm layer which helps in adherence and colonization
of smooth surfaces, especially prosthetic devices, shunts, and
catheters [8]. S. simulans has also been shown to share
virulence factors with S. aureus in infectious animal isolates,
including staphylococcal enterotoxins, tissue necrosis cy-
totoxin Panton–Valentine leukocidin, and the methicillin-
resistance gene, mecA [5]. (e encapsulated forms of S.
simulans (i.e., slime layer or bioﬁlm) have an antiphagocytic
eﬀect on human polymorphonuclear leucocytes as com-
pared to unencapsulated forms of the pathogen [8]. Se-
quencing of the tuf gene has been shown to be the most
accurate for the species identiﬁcation of CoNS [9].
(e critical event in the establishing the pathogenicity
includes formation of multilayered bioﬁlm, especially in
foreign body-associated infections caused by CoNS. Mem-
bers of the genus Staphylococcus produce various pro-
teinaceous and nonproteinaceous adhesins, to mediate
attachment to host surfaces, such as plasma extracellular and
matrix proteins or even host cells [10, 11].
(ere are limited data available about how CoNS which
are usually common pathogens in veterinary medicine are
gaining pathogenicity in human hosts. (ere are some
shared virulence factors with Staphylococcus aureus which
are documented in Table 2 [5, 12–14]. Of note, mecA-
positive CoNS are capable to horizontally transfer their
genes inside the staphylococcal genus with the prospective to
contribute increase in new methicillin-resistant strains [12].
(e challenging problem even after CoNS isolation and
identiﬁcation is the assessment of their clinical relevance.
(e major diagnostic question remains as to whether the
CoNS isolate represents a contamination of the specimen,
physiological colonization of the skin or mucus membranes,
or a clinically signiﬁcant infection. In our case, the absence
of other microbiological data and the conﬁdence in the
sterile process of procuring the sample from pleural ﬂuid
warranted consideration of S. simulans in the pleural ﬂuid as
pathogenic. Important considerations include isolation of
a strain in pure culture from the site of infection and re-
peated isolation of the same strain over the course of in-
fection [11, 15].
While treating the pleural infections, clinicians need to
be cognizant of the choice of antimicrobial therapy and
relevant pharmacokinetics. Major factors that inhibit the
penetration of antibiotics is the large-sized
eﬀusions/empyema, thickness of pleura, and the nature of
Table 1
Author Age/sex Diagnosis
Tissue
culture for S.
simulans
Blood
culture for S.
simulans
Antibiotic resistance Outcome Animalexposure
Shields
et al. [5] 80/M Right great toe cellulitis Positive Not speciﬁed Tetracycline resistance
Resolution with TMP-
SMX
Not
speciﬁed
Tous
Romero
et al. [6]
60/M Pyoderma left hand Positive Not speciﬁed Not speciﬁed Resolution withazithromycin Positive
Al Kline
et al. [8] 65/M
Abscess, osteomyelitis
right foot
Positive bone
culture Positive
Ampicillin,
ciproﬂoxacin,
clindamycin, oxacillin,
penicillin, ceftriaxone
Resolution with IV
vancomycin Positive
Vallianou
et al. [3] 46/M
Vertebral osteomyelitis,
native valve,
endocarditis
Not speciﬁed Positive Methicillin
Resolution with IV
vancomycin,
teicoplanin, oral
clindamycin
Positive
Sturgess
et al. [7] 77/F
Right pubic
osteomyelitis Not speciﬁed Positive Pan-sensitive
Resolution with
ﬂucloxacillin, fusidic
acid
Not
speciﬁed
de Jesus
et al. [2] 84/M
Septicemia, colon
cancer Not speciﬁed Positive Methicillin-sensitive Died
Not
speciﬁed
de Jesus
et al. [2] 41/M
Acute respiratory
failure, ARDS, H/O
HIV, IV drug abuse
Not speciﬁed Positive Methicillin-sensitive Died Notspeciﬁed
de Jesus
et al. [2] 63/M Pneumonia
CN staph in
sputum
Positive for
S. simulans Not speciﬁed
Resolved with
erythromycin,
cefuroxime
Not
speciﬁed
de Jesus
et al. [2] 58/M
Colon cancer,
septicemia Not speciﬁed Positive Methicillin-resistant
Resolved with
vancomycin
Not
speciﬁed
Males
et al. [1] 39/M
Right ankle,
osteomyelitis, septic,
arthritis
Positive Positive Pan-sensitive Penicillin Notspeciﬁed
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antibiotic itself; acute inﬂammation is proven to be a sup-
porting factor due to vasodilation [16, 17]. Teixeira et al.
demonstrated that penicillin has the best penetration for the
treatment of pleural pathologies, followed by metronidazole;
gentamicin was found to have poor penetration and con-
sidered a poor choice for treatment of empyemas [16].
S. simulans is known to demonstrate resistance to
multiple antibiotics including vancomycin [2]. In our case,
the organism was resistant to ampicillin/sulbactam, cefa-
zolin, ciproﬂoxacin, oxacillin, and tetracycline, but it was
susceptible to vancomycin in vitro.(e use of vancomycin in
pleural infections has long been debated due to its sub-
optimal penetration; however, in our case, the multidrug-
resistant nature of the isolate required its use. It is debatable
in retrospect if continuation of a broader antimicrobial
coverage would have changed the outcome for the patient,
considering poor biochemical and clinical response with the
chosen antibiotic regimen.
Source control for septic patients remains the corner-
stone of treatment along with optimal antimicrobial cov-
erage. (e MIST-2 study reiterated the fact where use of
t-PA and DNase combination therapy in patients with
pleural infection improved drainage of pleural empyema,
resulting in reduction in hospital stay and need for thoracic
surgery intervention [18].
3. Conclusion
Staphylococcus simulans, a coagulase-negative staphylo-
coccus, is emerging as an important cause of virulent in-
fections with high mortality in humans. Given its propensity
for multidrug resistance, including vancomycin, there is an
imperative for early and accurate identiﬁcation of the isolate.
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